Investigation of Sky Automatic Technologies in Pediatrics

Recruiting N/A Interventional Study
Hearing Loss
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
6 – 16
Sex
Any
Study type
Interventional
Purpose
Supportive Care
Participants needed
20 (estimated)
Sponsor
Assistance Publique - Hôpitaux de Paris · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The hypothesis of this research is that the AS Target setting provides the best estimate of the settings required to optimize listening in noise. As such, it is expected that speech in noise performance will be best in the AS Target condition, followed by the AS Clinic condition, and the Omni condition will be the least favourable for speech in noise performance.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Be between 6 and 16 years of age at the time of inclusion * Use spoken French as their primary mode of communication * Ability to perform the Simplified French Matrix test in Noise * Bimodal group: use the Sky CI processor or be eligible for a Sky CI processor upgrade on one s…
Contacts

Nathalie LOUNDON, MD, PhD

01 71 39 67 82

natalie.loundon@aphp.fr

CONTACT

Gael PLASTOW

0144381711

gael.plastow@aphp.fr

CONTACT